skip to Main Content

About Us
Expertise
Services
Phase I Units
Indications
Regions
Search

Open Mobile Menu

Search

Footer

About Us About Team Contact Expertise Biosimilars and biotech products Biosimilar Erythropoetin Biosimilar Insulins Trastuzumab Granulocyte Colony Stimulating Factor (G-CSF)Parathyroid Hormone Biosimilar Rituximab and Adalimumab Bioavailability and Bioequivalence Pharmacokinetic trials in patients Inhalation products Tiotropium Salmeterol / Fluticasone Salbutamol Budesonide Budesonide / Formoterol Topical and transdermal products Publications Request for Proposal Services Regulatory and Scientific Advice Medical Writing Regulatory Submissions for Clinical Trial Approval Project and Site Management Monitoring Quality Management Legal Represenative EU Responsible Person Pharmacovigilance Data Management Statistics Logistics and Insurance services Phase I Units Bulgaria I Bulgaria II Bulgaria III Indications Oncology Respiratory Diseases Inflammatory Diseases Ophthalmology Dermatology Metabolic Disease Nervous System Disorders Renal Disease Diabetes Cardiovascular Diseases Genito-Urinary System Women´s Health Regions Germany Bulgaria Poland Serbia Croatia Russia Ukraine Hungary Moldova Romania Spain Netherlands & Belgium

Regulatory and Scientific Advice
Medical Writing
Regulatory Submissions for Clinical Trial Approval
Project and Site Management
Monitoring
Quality Management
Legal Represenative EU
Responsible Person Pharmacovigilance
Data Management
Statistics
Logistics and Insurance services
Home

Oncology
Respiratory Diseases
Inflammatory Diseases
Ophthalmology
Dermatology
Metabolic Disease
Nervous System Disorders
Renal Disease
Diabetes
Cardiovascular Diseases
Genito-Urinary System
Women´s Health
Home

© CCDRD – Imprint – Privacy Policy

About Us
Expertise
Services
Phase I Units
Indications
Regions